Business
electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times
ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one of “The Americas’ Fastest Growing Companies 2025.” Debuting at number 125, electroCore joins 300 other companies dominating in their respective sectors. This is the sixth annual list that the Financial Times published, ranking companies based on the highest compound annual revenue growth between the
About this update from Electrocore, Inc.
[{"type":"image","alt":"electroCore, Inc.","displaySize":"","headline":null,"caption":"electroCore, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/7811b7d6996b3bdbba50262f0a2f8b72"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uvgACRsMp7ZiIRhie6e7ow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7811b7d6996b3bdbba50262f0a2f8b72","width":300,"height":85}},"lazy":false},{"type":"text","content":"ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one of “The Americas’ Fastest Growing Companies 2025.” Debuting at number 125, electroCore joins 300 other companies dominating in their respective sectors.","length":351,"tagName":"p"},{"type":"text","content":"This is the sixth annual list that the Financial Times published, ranking companies based on the highest compound annual revenue growth between the years 2020 and 2023. The healthcare & life sciences sector represented 10% of the of the fastest-growing companies. electroCore ranked 16 out of the other 29 healthcare & life sciences companies making the publication, including BeiGene, Hims & Hers Health and Progyny.","length":429,"tagName":"p"},{"type":"text","content":"“electroCore delivers substantial value to our customers, offering a drug-free method for addressing pain, reducing stress, and improving sleep,” stated Joshua Lev, CFO of electroCore. “The ranking by the Financial Times reflects this value, as well as the hard work of our team to commercialize our innovative technology.”","length":323,"tagName":"p"},{"type":"text","content":"The Americas’ Fastest Growing Companies 2025 list was announced on April 2, 2025, and can be currently viewed on the Financial Times website.","length":141,"tagName":"p"},{"type":"text","content":"About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS...